Why the study?
Does atorvastatin 40 mg improve endothelial function in asymptomatic metabolic syndrome patients?
Case-Control (n=100)
No
Does atorvastatin 40 mg improve endothelial function in asymptomatic metabolic syndrome patients?
Absolute Event Rate: 10.19% vs 6.73%
p-value: p=<0.001
Short-term treatment with 40 mg atorvastatin significantly improves endothelial function in asymptomatic patients with metabolic syndrome.
Should not yet change practice; hypothesis-generating for rapid endothelial effects of atorvastatin in metabolic syndrome.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mannuva et al. (2014) conducted a case-control in Asymptomatic Metabolic Syndrome (n=100). Atorvastatin vs. Baseline (before treatment) was evaluated on Brachial artery flow-mediated dilation (FMD%) (p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: